Table 2.
Focus group patient characteristics (N=93).
| Variable | Participants | |
| Site, n (%) | ||
| Birmingham | 27 (29) | |
| San Francisco | 30 (32) | |
| Seattle | 36 (39) | |
| Age in years (n=92), median (range) | 49 (23-71) | |
| Years since HIV diagnosis (n=92), median (range) | 16 (1-38) | |
| Gender, n (%) | ||
| Male | 56 (60) | |
| Female | 33 (35) | |
| Transgender | 4 (5) | |
| Race, n (%) | ||
| African American | 41 (44) | |
| White | 41 (44) | |
| Mixed race/other | 11 (12) | |
| Ethnicity, n (%) | ||
| Hispanic | 10 (11) | |
| Non-Hispanic | 83 (89) | |
| Injection drug use in past 12 months, n (%) | ||
| No | 76 (82) | |
| Yes | 17 (18) | |
| Sexual orientationa, n (%) | ||
| Bisexual | 12 (14) | |
| Heterosexual | 36 (41) | |
| Homosexual | 40 (45) | |
| Currently on antiretroviral therapyb, n (%) | ||
| No | 11 (13) | |
| Yes | 76 (87) | |
| Ever on antiretroviral therapyc, n (%) | ||
| No | 5 (5) | |
| Yes | 87 (95) | |
| Detectable viral loadd, n (%) | ||
| No | 55 (82) | |
| Yes | 12 (18) | |
aMissing n=5 due to data collection oversight.
bMissing n=6 due to data collection oversight.
cMissing n=1 due to data collection oversight.
dMissing n=26 due to data collection oversight.